Even as we witness the unrelenting growth of the hemp and cannabis markets across the U.S., most legal aspects of the industry continue to be shrouded in veritable shades of gray. Federal lawmakers remain stubborn in removing cannabidiol (CBD) from the DEA’s list of Controlled Substances, even though the compound has recently been approved by the FDA to treat two rare forms of epilepsy.
The owner of this website is not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that you obtain through this site. You are encouraged to confer with your doctor with regard to information contained on or through this web site. After reading articles or other content from this web site, you are encouraged to review the information carefully with your professional healthcare provider.